40 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
included in the accompanying Management's Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
with the limitations set forth in this Section 1 on the amount of Placement Shares issued and sold under this Agreement shall be the sole responsibility … responsibility against such losses and risks and in such amounts as are prudent and customary for companies of similar size as the Company in the businesses
424B5
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
by reference in this prospectus supplement or in the accompanying prospectus. We take no responsibility for, and can provide no assurance … or additional information, you should not rely on it. We take no responsibility for, and provide no assurance as to the reliability of any other
F-3
pag56ar5idm4un
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-1.1
s9sfznre
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
n12zr odc1pm3pf
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
70lpej0hy97x u0qet
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
lx56pg 724
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
ta0dkr6esrsim plbi
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-99.1
x16 un927i8os6jb
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
rkzexa
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
enr6ew0sfc8xczt57hv
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
hziyskbd7hx4ctcuq
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm